September 11, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: | NovaBay Pharmaceuticals, Inc. (the “Company”) Form S-3, File No. 333-233623 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective as of 5:00 p.m. (Eastern time) on Thursday, September 12, 2019, or as soon as practicable thereafter.
Very truly yours, | |||
NovaBay Pharmaceuticals, Inc. | |||
By: | /s/ Justin Hall | ||
Justin Hall | |||
President & Chief Executive Officer and General Counsel | |||
cc: | Abby E. Brown, Squire Patton Boggs (US) LLP | ||
